OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00289957

Impulse Qingdao Health Tech Co Ltd

Recreational ProductsVerified

Impulse Qingdao Health Tech Co Ltd maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.36, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.13, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow stands at 49.92 million CNY, which is lower than the operating cash flow of 126.32 million CNY, indicating some capital expenditure pressure. Profitability metrics show a return on equity of 3.59% and a return on assets of 2.22%, both below the typical thresholds for high-performing recreational product firms. The company's net income of 62.99 million CNY is supported by a gross profit of 309.80 million CNY, but the operating income of 74.10 million CNY suggests some operational inefficiencies or cost pressures. The company's revenue is primarily concentrated in its domestic market, with no disclosed international segments. This concentration may expose the company to regional economic fluctuations and regulatory changes. No specific geographic breakdown is provided, but the lack of diversification is a notable risk factor. Looking ahead, the company is projected to see a modest increase in revenue, with analyst estimates suggesting a mean revenue of 1.22 billion CNY for the current fiscal year, compared to the reported 1.18 billion CNY. This represents a growth rate of approximately 3.4%. The capital expenditure of -67.59 million CNY indicates a reduction in investment, which may signal a strategic shift or cost-cutting measures. Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's reliance on debt financing and the potential for future capital needs could introduce dilution pressure if new financing is required. Recent events include the publication of the latest financial report, which provides updated figures on revenue, profitability, and capital structure. No recent earnings call transcripts or major regulatory filings have been disclosed, but the company's financial performance remains within expected ranges for the recreational products industry.

30-day price · 002899+3.96 (+13.9%)
Low$27.57High$36.30Close$32.35As of15 May, 00:00 UTC
Profile
CompanyImpulse Qingdao Health Tech Co Ltd
Ticker002899.SZ
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryRecreational Products
AI analysis

Business. Impulse Qingdao Health Tech Co Ltd designs, produces, and sells recreational products, primarily focusing on health and wellness-related items, generating revenue through product sales to domestic and international markets.

Classification. Impulse Qingdao Health Tech Co Ltd is classified under the Consumer Cyclicals economic sector, Cyclical Consumer Products business sector, and Recreational Products industry, with a classification confidence of 0.92.

Impulse Qingdao Health Tech Co Ltd maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.36, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.13, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow stands at 49.92 million CNY, which is lower than the operating cash flow of 126.32 million CNY, indicating some capital expenditure pressure. Profitability metrics show a return on equity of 3.59% and a return on assets of 2.22%, both below the typical thresholds for high-performing recreational product firms. The company's net income of 62.99 million CNY is supported by a gross profit of 309.80 million CNY, but the operating income of 74.10 million CNY suggests some operational inefficiencies or cost pressures. The company's revenue is primarily concentrated in its domestic market, with no disclosed international segments. This concentration may expose the company to regional economic fluctuations and regulatory changes. No specific geographic breakdown is provided, but the lack of diversification is a notable risk factor. Looking ahead, the company is projected to see a modest increase in revenue, with analyst estimates suggesting a mean revenue of 1.22 billion CNY for the current fiscal year, compared to the reported 1.18 billion CNY. This represents a growth rate of approximately 3.4%. The capital expenditure of -67.59 million CNY indicates a reduction in investment, which may signal a strategic shift or cost-cutting measures. Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's reliance on debt financing and the potential for future capital needs could introduce dilution pressure if new financing is required. Recent events include the publication of the latest financial report, which provides updated figures on revenue, profitability, and capital structure. No recent earnings call transcripts or major regulatory filings have been disclosed, but the company's financial performance remains within expected ranges for the recreational products industry.
Key takeaways
  • Impulse Qingdao Health Tech Co Ltd has a moderate debt-to-equity ratio of 0.36, indicating a balanced capital structure.
  • The company's return on equity of 3.59% is below the industry average, suggesting room for improvement in profitability.
  • Revenue is primarily concentrated in the domestic market, increasing exposure to regional economic and regulatory risks.
  • Analysts project a modest revenue increase of 3.4% for the current fiscal year, with no significant capital expenditure planned.
  • The company faces medium liquidity risk and low dilution risk, with no immediate pressure for equity issuance.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.18B
Gross profit$309.8M
Operating income$74.1M
Net income$63.0M
R&D
SG&A
D&A
SBC
Operating cash flow$126.3M
CapEx-$67.6M
Free cash flow$49.9M
Total assets$2.84B
Total liabilities$1.09B
Total equity$1.75B
Cash & equivalents
Long-term debt$634.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.18B$74.1M$63.0M$49.9M
FY-1$1.21B$123.7M$109.1M-$79.8M
FY-2$895.3M$101.6M$88.2M-$237.8M
FY-3$824.7M$45.7M$65.7M-$393.3M
FY-4$864.4M$39.9M$17.4M-$404.9M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$2.84B$1.75B
FY-1$2.95B$1.70B
FY-2$2.29B$1.24B
FY-3$2.03B$1.16B
FY-4$1.78B$1.10B
PeriodOCFCapExFCFSBC
FY0$126.3M-$67.6M$49.9M
FY-1$237.4M-$204.8M-$79.8M
FY-2$260.0M-$307.8M-$237.8M
FY-3$104.4M-$455.0M-$393.3M
FY-4$62.2M-$432.4M-$404.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$295.7M$16.8M$15.0M
FQ-1$320.2M$12.8M$12.0M
FQ-2$281.2M$21.6M$19.1M
FQ-3$283.9M$25.1M$17.5M
FQ-4$290.6M$15.1M$14.2M
FQ-5$317.6M$25.5M$21.8M
FQ-6$324.4M$39.6M$36.1M
FQ-7$333.4M$43.3M$37.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$2.86B$1.77B$193.3M
FQ-1$2.84B$1.75B
FQ-2$2.83B$1.74B$324.9M
FQ-3$2.86B$1.72B
FQ-4$2.89B$1.72B$459.5M
FQ-5$2.95B$1.70B
FQ-6$2.96B$1.68B$433.4M
FQ-7$2.84B$1.65B
PeriodOCFCapExFCFSBC
FQ0-$38.3M-$12.4M
FQ-1$126.3M-$67.6M
FQ-2$108.6M-$51.7M
FQ-3$51.8M-$41.0M
FQ-4-$48.6M-$37.9M
FQ-5$237.4M-$204.8M
FQ-6$77.9M-$147.2M
FQ-7$27.4M-$83.6M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.75B
Net cash-$634.0M
Current ratio2.1
Debt/Equity0.4
ROA2.2%
ROE3.6%
Cash conversion2.0%
CapEx/Revenue-5.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Recreational Products · cohort 1 companies
Metric002899Activity
Op margin6.3%-0.8% medp25 -0.8% · p75 -0.8%top quartile
Net margin5.4%-2.6% medp25 -2.6% · p75 -2.6%top quartile
Gross margin26.3%27.7% medp25 17.4% · p75 41.4%below median
R&D / revenue3.1% medp25 3.1% · p75 3.1%
CapEx / revenue-5.8%3.1% medp25 3.1% · p75 3.1%bottom quartile
Debt / equity36.0%111.1% medp25 111.1% · p75 111.1%bottom quartile
Observations
IR observations
Mean EPS estimate0.43 CNY
Mean revenue estimate1,218,750,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:31 UTCJob: 57b92fc3